MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 01-08-2026
Country |
 USA |
IPO year |
1989 |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ GLOBALSPB |
Shares |
217 M |
Market Cap[1] |
$ 2.34 B |
EBITDA (LTM) |
$ 119 M |
P/E (LTM) |
-5.47 |
P/S (LTM) |
2.75 |
EPS (LTM) |
-2.05 |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Anixa Biosciences
ANIX
|
$ 2.81 | -5.07 % | $ 91.2 K | Nasdaq Capital Market | USA |
 |
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
 |
Agilent Technologies
A
|
$ 115.28 | -2.41 % | $ 35 B | NYSE,SPB | USA |
 |
Celcuity
CELC
|
$ 105.92 | -2.2 % | $ 4.18 B | Nasdaq Global Select Market | USA |
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market |  Britain |
 |
Charles River Laboratories International
CRL
|
$ 174.83 | -2.13 % | $ 8.67 B | NYSE,SPB | USA |
 |
Castle Biosciences
CSTL
|
$ 27.33 | -2.38 % | $ 759 M | Nasdaq Global Market,SPB | USA |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE |  China |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
|
Biodesix
BDSX
|
$ 15.79 | 0.25 % | $ 2.05 B | Nasdaq Global Market | USA |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
BioNano Genomics
BNGO
|
$ 1.11 | -2.98 % | $ 1.41 M | Nasdaq Capital Market,SPB | USA |
 |
Quest Diagnostics Incorporated
DGX
|
$ 206.04 | -2.01 % | $ 22.9 B | NYSE,SPB | USA |
 |
Danaher Corporation
DHR
|
$ 201.56 | -2.1 % | $ 144 B | NYSE,SPB | USA |
 |
Exact Sciences Corporation
EXAS
|
$ 103.21 | -0.14 % | $ 19.5 B | Nasdaq Capital Market,SPB | USA |
 |
Bioventus
BVS
|
$ 8.64 | -1.48 % | $ 541 M | Nasdaq Global Select Market | USA |
 |
DarioHealth Corp.
DRIO
|
$ 10.65 | -0.93 % | $ 302 M | Nasdaq Capital Market |  Israel |
 |
DexCom
DXCM
|
$ 73.18 | -0.76 % | $ 28.6 B | Nasdaq Global Select Market,SPB | USA |
 |
Fulgent Genetics
FLGT
|
$ 13.83 | -2.61 % | $ 418 M | Nasdaq Global Market | USA |
 |
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE |  Niderland |
 |
Burning Rock Biotech Limited
BNR
|
$ 24.58 | -2.31 % | $ 258 M | Nasdaq Global Market | China |
 |
CareDx, Inc
CDNA
|
$ 18.18 | -3.04 % | $ 969 M | Nasdaq Global Market,SPB | USA |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | Israel |
 |
ICON Public Limited Company
ICLR
|
$ 104.16 | -3.8 % | $ 8.59 B | Nasdaq Global Select Market,SPB |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
$ 639.92 | 0.5 % | $ 51.5 B | Nasdaq Global Select Market,SPB | USA |
 |
Illumina
ILMN
|
$ 127.58 | -4.0 % | $ 20.3 B | Nasdaq Global Select Market,SPB | USA |
 |
Guardant Health
GH
|
$ 89.06 | -3.44 % | $ 11.2 B | Nasdaq Global Select Market,SPB | USA |
 |
IQVIA Holdings
IQV
|
$ 169.62 | -2.68 % | $ 29.2 B | NYSE,SPB | USA |
 |
Brainsway Ltd.
BWAY
|
$ 22.34 | -5.7 % | $ 99.4 M | Nasdaq Global Select Market | Israel |
 |
Co-Diagnostics
CODX
|
- | - | $ 79.8 M | Nasdaq Capital Market | USA |
 |
Laboratory Corporation of America Holdings
LH
|
$ 280.14 | -2.14 % | $ 23.3 B | NYSE,SPB | USA |
 |
Lantheus Holdings
LNTH
|
$ 76.61 | 0.41 % | $ 5.17 B | Nasdaq Global Select Market,SPB | USA |
 |
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | USA |
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
 |
Mettler-Toledo International
MTD
|
$ 1 301.22 | -1.65 % | $ 26.8 B | NYSE,SPB |  Schweiz |
 |
Myriad Genetics
MYGN
|
$ 4.9 | -2.2 % | $ 454 M | Nasdaq Global Select Market,SPB | USA |
 |
NeoGenomics
NEO
|
$ 9.15 | -3.68 % | $ 1.17 B | Nasdaq Global Select Market,SPB | USA |
 |
Natera
NTRA
|
$ 195.49 | -2.34 % | $ 19.2 B | Nasdaq Global Select Market,SPB | USA |
 |
Pacific Biosciences of California
PACB
|
$ 1.51 | -6.5 % | $ 453 M | Nasdaq Global Select Market,SPB | USA |
 |
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | USA |
 |
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | USA |
 |
Precipio
PRPO
|
$ 24.76 | 0.32 % | $ 32.1 M | Nasdaq Global Select Market | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.